9 Antiphospholipid Syndrome Clinical Trials in Cleveland, OH (2026)

Q: How do I join a clinical trial in Cleveland?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Cleveland research site will contact you.

Recruiting Antiphospholipid Syndrome Studies in Cleveland

NCT06393738Recruiting

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

This clinical trial is studying the safety and potential anti-tumor activity of an investigational drug called ARV-393 in patients diagnosed with advanced Relapsed/Refractory non-Hodgkin's lymphoma (R...

Cleveland, OHPHASE1329 participantsArvinas Inc.

View Study Details

NCT07325136Recruiting

A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination With Nivolumab in Participants With Relapsed/Refractory Small Cell Lung Cancer

The purpose of this study is to assess the safety and tolerability of BMS-986525 alone and in combination with Nivolumab in participants with Relapsed/Refractory Small Cell Lung Cancer...

Cleveland, OHPHASE1240 participantsBristol-Myers Squibb

View Study Details

NCT06738537Recruiting

Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse

This is a qualitative and quantitative study that seeks to obtain information from patients with degenerative mitral valve prolapse and providers regarding factors important in deciding between surgic...

Cleveland, OH150 participantsNorthwell Health

View Study Details

NCT07471464Recruiting

Centered Surgery - Preoperative Counseling and Patient Satisfaction

This study is a prospective cohort study which aims to assess patient satisfaction and preparedness for surgery through two methods of preoperative counseling: standard individual phone calls versus v...

Cleveland, OH106 participantsThe Cleveland Clinic

View Study Details

NCT07681596Recruiting

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

The purpose of this study is to assess the safety, tolerability, preliminary efficacy, cellular kinetics, and other exploratory endpoints of AZD4045 as a monotherapy and in association with daratumuma...

Cleveland, OHPHASE1101 participantsAstraZeneca

View Study Details

NCT05780034Recruiting

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

This clinical trial is evaluating a drug called AC676 in participants with Relapsed/Refractory B-cell Malignancies. The main goals of the study are to: * Identify the recommended dose of AC676 that c...

Cleveland, OHPHASE160 participantsAccutar Biotechnology Inc

View Study Details

NCT05722418Recruiting

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

This is a Phase 1 study to evaluate the safety of CB-011 (the study treatment), an allogeneic chimeric antigen receptor (CAR-T) cell therapy that targets the B cell maturation antigen (BCMA), to deter...

Cleveland, OHPHASE150 participantsCaribou Biosciences, Inc.

View Study Details

NCT05210374Recruiting

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

The purpose of this study is to test the safety of combining the disulfiram (DSF) and copper gluconate (Cu) to liposomal doxorubicin to treat patients with sarcomas that recurred or did not respond to...

Cleveland, OHPHASE124 participantsCase Comprehensive Cancer Center

View Study Details

NCT06916767Recruiting

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

CAR-T cell treatment of refractory lymphoma has shown success, particularly with CD-19 targeted CAR-T cells, however, many participants are refractory or relapse after response. Responses are more lim...

Cleveland, OHPHASE118 participantsPaolo Caimi, MD

View Study Details

About Antiphospholipid Syndrome Clinical Trials in Cleveland

Antiphospholipid syndrome is an autoimmune disorder that increases the risk of blood clots in arteries and veins, and pregnancy complications. It occurs when the immune system makes antibodies that attack phospholipids. Treatment primarily involves anticoagulant medications.

There are currently 9 antiphospholipid syndrome clinical trials recruiting participants in Cleveland, OH. These studies are seeking a combined 1,078 participants. Research is being sponsored by Arvinas Inc., Bristol-Myers Squibb, Northwell Health and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Antiphospholipid Syndrome Clinical Trials in Cleveland — FAQ

Are there antiphospholipid syndrome clinical trials in Cleveland?

Yes, there are 9 antiphospholipid syndrome clinical trials currently recruiting in Cleveland, OH. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Cleveland?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cleveland research site will contact you about next steps.

Are clinical trials in Cleveland free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cleveland studies also compensate for your time and travel.

What antiphospholipid syndrome treatments are being tested?

The 9 active trials in Cleveland are testing new therapies including novel drugs, biologics, and treatment approaches for antiphospholipid syndrome.

Data updated October 15, 2026 from ClinicalTrials.gov